Wolf-Levin R, Azuma T, Aoki K, Yagami Y, Okada H
Department of Molecular Biology, Nagoya City University School of Medicine, Japan.
J Immunol. 1993 Nov 15;151(10):5864-77.
PHA-activated human T cells express MHC class II molecules and have been shown to stimulate autoreactive T cells in autologous mixed lymphocyte reaction (T-T AMLR). We now demonstrate that normal human serum can dramatically suppress the proliferative response in T-T AMLR. The inhibitory factor was detected in the IgG fraction, and the activity was found to be mediated through the F(ab')2 portion of the IgG molecule, implying that the inhibitor could be specific. All homologous as well as autologous sera tested contained the inhibitory activity. Human serum was also found to suppress allogenic MLR stimulated by PHA-activated T lymphocytes but not allogenic MLR stimulated by nonactivated PBMC, indicating that the mechanism of inhibition is related to PHA activation of the stimulator cells. Moreover, pretreatment of the PHA-activated T lymphocytes with human serum resulted in a significant inhibition of T-T AMLR, as opposed to pretreatment of nonactivated PBMC, indicating that PHA-activated stimulators are functionally involved in the inhibition. Cytofluorometric analysis revealed that autologous IgG specifically binds to PHA-activated T lymphocytes and not to nonactivated CD3+ T cells. Furthermore, serum absorbed by PHA-activated T lymphocytes substantially lost its inhibitory activity whereas serum absorbed by nonactivated PBMC did not, suggesting that a surface molecule(s) expressed during activation of the stimulator cells is involved in the inhibition. The addition of human serum later in the culture period (> 3 days) resulted in a marked decrease in inhibition, implying that the presence of IgG in the early recognition phase of T-T AMLR is essential for maximum inhibitory effect. These results raise the possibility that natural autoantibodies present in normal human IgG may play an important role in regulating immune response mediated by autoreactive T cells.
PHA激活的人T细胞表达II类主要组织相容性复合体分子,并已证实在自体混合淋巴细胞反应(T-T AMLR)中可刺激自身反应性T细胞。我们现在证明,正常人血清可显著抑制T-T AMLR中的增殖反应。在IgG组分中检测到抑制因子,并且发现该活性是通过IgG分子的F(ab')2部分介导的,这意味着该抑制剂可能具有特异性。所有测试的同源以及自体血清均含有抑制活性。还发现人血清可抑制由PHA激活的T淋巴细胞刺激的同种异体混合淋巴细胞反应,但不能抑制由未激活的外周血单个核细胞刺激的同种异体混合淋巴细胞反应,这表明抑制机制与刺激细胞的PHA激活有关。此外,用人血清预处理PHA激活的T淋巴细胞会导致T-T AMLR受到显著抑制,这与未激活的外周血单个核细胞的预处理情况相反,表明PHA激活的刺激细胞在功能上参与了抑制作用。细胞荧光分析显示,自体IgG特异性结合PHA激活的T淋巴细胞,而不结合未激活的CD3+ T细胞。此外,被PHA激活的T淋巴细胞吸收的血清基本上失去了其抑制活性,而被未激活的外周血单个核细胞吸收的血清则没有,这表明刺激细胞激活过程中表达的一种或多种表面分子参与了抑制作用。在培养期后期(> 3天)添加人血清会导致抑制作用显著降低,这意味着在T-T AMLR的早期识别阶段存在IgG对于最大抑制效果至关重要。这些结果增加了正常人IgG中存在的天然自身抗体可能在调节自身反应性T细胞介导的免疫反应中起重要作用的可能性。